Scott Tarriff

2017

In 2017, Scott Tarriff earned a total compensation of $8M as Chief Executive Officer, Director at Eagle Pharmaceuticals, a 12% increase compared to previous year.

Compensation breakdown

Bonus$523,000
Option Awards$6,742,833
Salary$747,000
Other$29,095
Total$8,041,928

Tarriff received $6.7M in option awards, accounting for 84% of the total pay in 2017.

Tarriff also received $523K in bonus, $747K in salary and $29.1K in other compensation.

Rankings

In 2017, Scott Tarriff's compensation ranked 943rd out of 14,666 executives tracked by ExecPay. In other words, Tarriff earned more than 93.6% of executives.

ClassificationRankingPercentile
All
943
out of 14,666
94th
Division
Manufacturing
319
out of 5,772
95th
Major group
Chemicals And Allied Products
82
out of 2,075
96th
Industry group
Drugs
55
out of 1,731
97th
Industry
Pharmaceutical Preparations
45
out of 1,333
97th
Source: SEC filing on April 30, 2018.

Tarriff's colleagues

We found five more compensation records of executives who worked with Scott Tarriff at Eagle Pharmaceuticals in 2017.

2017

David Pernock

Eagle Pharmaceuticals

President and Chief Commercial Officer

2017

Adrian Hepner

Eagle Pharmaceuticals

Chief Medical Officer

2017

Steven Krill

Eagle Pharmaceuticals

Chief Scientific Officer

2017

Pete Meyers

Eagle Pharmaceuticals

Chief Financial Officer

2017

David Riggs

Eagle Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like